Hypoactive Sexual Desire Disorder
Showing 1 - 25 of >10,000
Hypoactive Sexual Desire Disorder Trial in San Diego (Oral Testosterone Undecanoate)
Not yet recruiting
- Hypoactive Sexual Desire Disorder
- Oral Testosterone Undecanoate
-
San Diego, CaliforniaSan Diego Sexual Medicine
Oct 12, 2023
Hypoactive Sexual Desire Disorder Trial in Seoul (Bremelanotide, Placebo)
Recruiting
- Hypoactive Sexual Desire Disorder
- Bremelanotide
- Placebo
-
Seoul, Korea, Republic ofSeoul National University Hospital
May 15, 2022
Hypoactive Sexual Desire Disorder Trial in London (Bremelanotide, Placebo)
Recruiting
- Hypoactive Sexual Desire Disorder
- Bremelanotide
- Placebo
-
London, United KingdomImperial College Healthcare NHS Trust
Mar 9, 2022
Sexuality, Sexual Dysfunction, Sexual Desire Disorder Trial in Los Angeles (Vibrator)
Recruiting
- Sexuality
- +9 more
- Vibrator
-
Los Angeles, CaliforniaCedars Sinai Medical Center
Jul 18, 2022
Hypoactive Sexual Desire Disorder Trial in San Diego (sex therapy, flibanserin)
Terminated
- Hypoactive Sexual Desire Disorder
- sex therapy
- flibanserin
-
San Diego, CaliforniaSan Diego Sexual Medicine
Jun 8, 2022
Hypoactive Sexual Desire Disorder Trial in Chicago (Flibanserin, Placebo)
Unknown status
- Hypoactive Sexual Desire Disorder
- Flibanserin
- Placebo
-
Chicago, IllinoisUniversity of Chicago
Jan 15, 2021
Hypoactive Sexual Desire Disorder Trial in Bochum (Cognitive-behavioral treatment, Mindfulness-based treatment)
Unknown status
- Hypoactive Sexual Desire Disorder
- Cognitive-behavioral treatment
- Mindfulness-based treatment
-
Bochum, NRW, GermanyRuhr University Bochum
Oct 6, 2020
Hypoactive Sexual Desire Disorder (HSDD) Trial in United States (Placebo Vaginal Insert, Prasterone 6.5 mg (0.50%) Vaginal
Withdrawn
- Hypoactive Sexual Desire Disorder (HSDD)
- Placebo Vaginal Insert
- Prasterone 6.5 mg (0.50%) Vaginal Insert
-
Huntsville, Alabama
- +9 more
Jul 29, 2020
Hypoactive Sexual Desire Disorder Trial in Canada, United States (Placebo Vaginal Insert, Prasterone 6.5 mg (0.50%) Vaginal
Completed
- Hypoactive Sexual Desire Disorder
- Placebo Vaginal Insert
- Prasterone 6.5 mg (0.50%) Vaginal Insert
-
Huntsville, Alabama
- +68 more
Apr 7, 2021
Menopause, Metabolic Syndrome, Hypoactive Sexual Desire Disorder Trial in São Paulo (Female sexual function index questionnaire,
Completed
- Menopause
- +4 more
- Female sexual function index questionnaire
- +2 more
-
São Paulo, BrazilRua Maria José Pomar, 322 Apartamento 172 C
Dec 30, 2019
Hypoactive Sexual Desire Disorder Trial in Canada, United States (testosterone gel, gel)
Completed
- Hypoactive Sexual Desire Disorder
- testosterone gel
- placebo gel
-
Birmingham, Alabama
- +148 more
Oct 27, 2021
Female Sexual Interest/Arousal Disorder Trial in Castelldefels (Libicare, active control)
Not yet recruiting
- Female Sexual Interest/Arousal Disorder
- Libicare
- active control
-
Castelldefels, Barcelona, SpainProcare Health Iberia
Dec 1, 2022
Hypoactive Sexual Desire Disorder Trial in Waukesha (Placebo vulvar cream, Estradiol vulvar cream)
Completed
- Hypoactive Sexual Desire Disorder
- Placebo vulvar cream
- Estradiol vulvar cream
-
Waukesha, WisconsinWaukesa Memorial Hospital
Mar 11, 2020
Hypoactive Sexual Desire Disorder Trial in Canada, United States (Bremelanotide, Placebo)
Completed
- Hypoactive Sexual Desire Disorder
- Bremelanotide
- Placebo
-
Birmingham, Alabama
- +90 more
Mar 16, 2021
Clitoral Arteries' Hemodynamic Parameters.
Completed
- Hypoactive Sexual Desire Disorder
- +5 more
- Testosterone gel
- +3 more
-
Florence, ItalyAndrology, Women's Endocrinology and Gender Incongruence Unit, U
Apr 3, 2020
Hypoactive Sexual Desire Disorder(HSDD) Trial in Saint Petersburg (BP101, Placebo)
Completed
- Hypoactive Sexual Desire Disorder(HSDD)
- BP101
- Placebo
-
Saint Petersburg, Russian FederationResearch center Eco-Safety LLC
Feb 10, 2020
Hypoactive Sexual Desire Disorder Trial in Canada, United States (Bremelanotide, Placebo)
Completed
- Hypoactive Sexual Desire Disorder
- Bremelanotide
- Placebo
-
Birmingham, Alabama
- +90 more
Jan 26, 2021
Hypoactive Sexual Desire Disorder Trial in London (Intrinsa Transdermal testosterone patch)
Completed
- Hypoactive Sexual Desire Disorder
- Intrinsa Transdermal testosterone patch
-
London, United Kingdom
- +2 more
Dec 13, 2019
Sexual Desire Disorder Trial in Santa Monica (DLM - Test product)
Completed
- Sexual Desire Disorder
- DLM - Test product
-
Santa Monica, CaliforniaCitruslabs
Jan 5, 2022
Hypoactive Sexual Desire Disorder, Female Sexual Dysfunction, Sexual Desire Disorder Trial in Russian Federation (BP101,
Completed
- Hypoactive Sexual Desire Disorder
- +2 more
- BP101
- Placebo
-
Barnaul, Russian Federation
- +19 more
Feb 10, 2020
Sexual Dysfunctions, Psychological, Hypoactive Sexual Desire Disorder, Erectile Dysfunctions Trial in Kuala Lumpur (Bupropion
Completed
- Sexual Dysfunctions, Psychological
- +2 more
- Bupropion hydrochloride sustained-release
- placebo
-
Kuala Lumpur, Selangor, MalaysiaUniversity Malaya Medical Center
Jul 17, 2019
Sexual Behavior, Sexual Orientation Conflict Disorder, Sexual Arousal Disorder Trial in Nasiriyah (H - Test)
Enrolling by invitation
- Sexual Behavior
- +4 more
- H - Test
-
Nasiriyah, Thi Qar, IraqNo name
Dec 11, 2020
LOng COvid COmorbidities: Andrological, Reproductive, Sexual
Recruiting
- Long Covid-19
- Assessment of andrological profile of LO-COCO-ANDRO male patients
- +3 more
-
Naples, ItalyFederico II University of Naples
May 21, 2022
Stress Urinary Incontinence Trial (laser and High intensity Tesla magnetic stimulation, laser (without HITS treatment))
Not yet recruiting
- Stress Urinary Incontinence
- laser and High intensity Tesla magnetic stimulation
- laser (without HITS treatment)
- (no location specified)
Jan 1, 2023
Stress Hormones, Mood and Women's Sexual Desire (MODEST)
Completed
- Hypoactive Sexual Desire Disorder (HSDD)
-
Vancouver, British Columbia, CanadaBritish Columbia Centre for Sexual Medicine
Oct 15, 2018